Business Update1 Jun 2026, 06:41 pm
Nureca Revises Capex to ₹128 Cr from ₹100 Cr
AI Summary
Nureca Ltd issued a corrigendum to its board meeting outcome submitted on May 29, 2026, revising the approved incremental capital expenditure (capex) for plant and machinery from ₹100 crores to ₹128 crores. This investment targets the manufacturing of additional medical devices, healthcare consumables, and hygiene products at the existing company-owned industrial land in Sundran, Dera Bassi, Punjab. The board also reaffirmed its approval for purchasing additional land for future expansion. All other contents of the original board meeting outcome remain unchanged.
Key Highlights
- Nureca revises capex for plant and machinery to ₹128 Cr.
- Revised capex will fund manufacturing of medical devices and consumables.
- Company reaffirms land purchase for future expansion in Punjab.
- Corrigendum addresses typographical error in the capex amount.
Price Impact
More from NURECA